Showing 30 of 4110 posts
Aterian’s 2025 results: trading revenue rises, exploration advances, but widening losses and tight cash leave going concern a key risk.
JoshuaMay 1, 2026
NatWest Markets Q1 2026 profit halved to £28m amid market volatility, but strong capital and litigation progress offer stability.
JoshuaMay 1, 2026
NatWest raises 2026 income guidance after strong Q1 with solid lending growth, cost control, and robust capital. Impairments rose but outlook remains positive.
JoshuaMay 1, 2026
Scott Oriental Trust's NAV fell 2.3% as benchmark surged; conditional tender offer looms if five-year performance fails.
JoshuaMay 1, 2026
ACCRUFeR sales surge 54% as Shield hits positive EBIT, but $7.9M milestone flatters numbers. CFO exits, NY Medicaid risk awaits.
JoshuaMay 1, 2026
Team PLC completes EPIC Guernsey acquisition, paying with 5.2m new shares. Strategic fit for wealth management but dilution hits 4.6%.
JoshuaMay 1, 2026
MJ Gleeson reports resilient trading but warns on legacy costs and Middle East uncertainty, with adjusted profit guidance conditional on major land sale.
JoshuaMay 1, 2026
Pulsar Group's FY25 results show strong ARR growth to £64.5m and improved profitability, though statutory losses widened. Cost cutting and AI product push mark a transition.
JoshuaMay 1, 2026
Mkango files Songwe Hill DFS, reports US$3.1m cash, raises £11.7m, and advances HyProMag recycling with first customer shipments.
JoshuaMay 1, 2026
RMII wind-down returns 50% capital, but NAV falls 10% as riskier assets remain. Key insights on Beinbauer, Energie, Trianco.
JoshuaMay 1, 2026
Unilever Q1 2026 update: 3.8% underlying sales growth driven by 2.9% volume growth, plus major Foods combination with McCormick.
JoshuaApril 30, 2026
AIB Group's Q1 2026 shows strong loan growth and solid capital, with full-year guidance reiterated despite lower interest rates.
JoshuaApril 30, 2026
Ferro-Alloy Resources' updated Balasausqandiq feasibility study shows sharply improved economics: US$311.9m funding, US$931.6m NPV, 31% IRR. A pivotal moment for the vanadium developer?
JoshuaApril 30, 2026
Ecofin US Renewables Trust reports 2025 results amid managed wind-down: asset sales progress but 46% NAV discount persists. Key risks and outlook.
JoshuaApril 30, 2026
Iofina's record 2025: iodine production +17%, revenue +22%, EBITDA +56%. Permian Basin expansion with larger plant underway. Strong outlook.
JoshuaApril 30, 2026
Seplat Energy Q1 2026: production slightly lower but cash flow strong, debt cut 21%, and dividend raised to 9.0 cents per share. April output recovery signals optimism.
JoshuaApril 30, 2026
Zenith Energy spins out Italian uranium portfolio into Reveille Resources, preserving upside via equity stake ahead of planned Aquis listing.
JoshuaApril 30, 2026
IG Design Group reports FY2026 results ahead of expectations: revenue $292m, net cash $72m. Also acquires Glenart S.A. for £5.3m – a disciplined bolt-on.
JoshuaApril 30, 2026
eEnergy FY25: revenue fell on new accounting policy but EBITDA turned positive, margins improved & FY26 guidance upgraded to £38m. Record pipeline of £127m. More inside.
JoshuaApril 30, 2026
Getech reports return to positive EBITDA and revenue growth in FY2025 results. Explore the key numbers, what drove the recovery, and the outlook for AIM investors.
JoshuaApril 30, 2026
Weir Group Q1 trading update: orders up 4%, guidance reaffirmed. But organic orders fell 3% as acquisitions drove headline growth. Mining demand strong.
JoshuaApril 30, 2026
For investors: Brave Bison FY25 results beat consensus with 60% net revenue growth and upgraded FY26 outlook, though acquisition costs hit statutory profit.
JoshuaApril 30, 2026
Renew Holdings buys Edwards Diving for up to £13m, boosting its specialist water infrastructure services. The deal is immediately earnings enhancing and positions Renew for the AMP8 investment cycle.
JoshuaApril 30, 2026
Kelso Group FY25: softer year-end but NAV jumps to 2.6p in 2026 – portfolio momentum rebuilding.
JoshuaApril 30, 2026
Fadel Partners FY2025: ARR up 14% to $8.9m, adjusted EBITDA loss narrows 81%. Revenue mix improves, but cash falls to $1.9m.
JoshuaApril 30, 2026
Synthomer FY2025: margins up to 7.8%, free cash flow positive, net debt lower. Refinancing extends to 2029. Key takeaways from the chemicals group's results.
JoshuaApril 30, 2026
Standard Chartered posts record Q1 2026 profit of $2.5B (+17%) despite $190M Middle East provision. Wealth Solutions income surged 32%.
JoshuaApril 30, 2026
evoke PLC posts FY25 results: Adjusted EBITDA up 14% but UK duty hikes force £440m impairment. Strategic review and 50p offer approach in focus.
JoshuaApril 30, 2026
JoshuaApril 30, 2026
Kazatomprom Q1 2026: production and prices rise, but sales dip 40% on timing. Full-year guidance held, chunky dividend recommended. Uranium demand outlook stays supportive.
JoshuaApril 30, 2026